Cargando…
Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy
Autores principales: | Montfort, Anne, Colacios, Céline, Levade, Thierry, Andrieu-Abadie, Nathalie, Meyer, Nicolas, Ségui, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817917/ https://www.ncbi.nlm.nih.gov/pubmed/31695705 http://dx.doi.org/10.3389/fimmu.2019.02515 |
Ejemplares similares
-
The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019) -
Anti-TNF, a magic bullet in cancer immunotherapy?
por: Montfort, Anne, et al.
Publicado: (2019) -
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
por: Bertrand, Florie, et al.
Publicado: (2017) -
Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma
por: Bilal, Fatima, et al.
Publicado: (2019) -
New Insights into the Role of Sphingolipid Metabolism in Melanoma
por: Carrié, Lorry, et al.
Publicado: (2020)